chitosan has been researched along with Pulmonary Hypertension in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bader, AR; Handy, DE; Hou, TK; Kao, DD; Kohane, DS; Loscalzo, J; Maron, BA; Qian, R; Yin, T; Zhang, YY | 1 |
1 other study(ies) available for chitosan and Pulmonary Hypertension
| Article | Year |
|---|---|
SDF-1α in glycan nanoparticles exhibits full activity and reduces pulmonary hypertension in rats.
Topics: Aerosols; Animals; Chemokine CXCL12; Chitosan; Dextran Sulfate; Humans; Hypertension, Pulmonary; Jurkat Cells; Male; Monocrotaline; Nanoparticles; Polysaccharides; Rats; Rats, Sprague-Dawley; Time Factors | 2013 |